U.S. FDA advisers back authorization of Moderna COVID vaccine for ages 6-17
- Oops!Something went wrong.Please try again later.
- MRNA
(Reuters) - Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna Inc's COVID-19 vaccine for children and teens aged 6 to 17 years of age.
(Reporting by Manas Mishra in Bengaluru; Editing by Chris Reese)